REG4 is an indicator for KRAS mutant lung adenocarcinoma with TTF-1 low expression

Si Sun1,2, Zhihuang Hu1,2, Shenglin Huang3

  • 1Department of Medical Oncology, Fudan University Shanghai Cancer Center, 270 Dong An Road, Shanghai, 200032, China.

Abstract

Insights

Researchers identified REG4 as a key biomarker in KRAS-driven lung adenocarcinoma, particularly the KC subtype. Silencing REG4 reduced tumor growth, suggesting its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung adenocarcinoma (LUAD) with KRAS mutation is classified into KP, KL, and KC subtypes based on co-occurring genetic events.
  • The KC subtype is characterized by CDKN2A/B inactivation and low TTF-1 expression.
  • Identifying specific molecular drivers is crucial for understanding LUAD pathogenesis, especially in the KC subtype.

Purpose of the Study:

  • To identify novel biomarkers contributing to lung adenocarcinoma pathogenesis.
  • To investigate the role of candidate molecules, particularly in the KC subtype of KRAS-mutant LUAD.

Main Methods:

  • Analysis of public datasets (E-GEOD-31210, TCGA) to identify candidate molecules.
  • Validation using quantitative real-time PCR in an independent cohort of 55 clinical samples.
  • Functional studies including in vitro and in vivo assays after REG4 silencing, coupled with RNA sequencing and Gene Set Enrichment Analysis (GSEA).

Main Results:

  • REG4, a regulator of gastrointestinal carcinogenesis, was found to be highly expressed in KRAS-mutant LUAD with low TTF-1 expression (KC subtype).
  • Gene expression analysis and immunohistochemistry confirmed high REG4 expression in an independent clinical cohort.
  • Silencing REG4 significantly reduced cancer cell proliferation and tumorigenesis, potentially by inducing cell cycle arrest via G2/M checkpoint and E2F targets.

Conclusions:

  • REG4 plays a significant role in the pathogenesis of KRAS-driven lung cancer.
  • REG4 is identified as a novel biomarker for a specific lung adenocarcinoma subtype.
  • Further research is warranted to elucidate REG4's mechanisms in KC tumor division and proliferation and its therapeutic potential.

Related Concept Videos

Indicators02:39

Indicators

Certain organic substances change color in dilute solution when the hydronium ion concentration reaches a particular value. For example, phenolphthalein is a colorless substance in any aqueous solution with a hydronium ion concentration greater than 5.0 × 10−9 M (pH < 8.3). In more basic solutions where the hydronium ion concentration is less than 5.0 × 10−9 M (pH > 8.3), it is red or pink. Substances such as phenolphthalein, which can be used to determine the pH of a solution, are...
59.7K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.1K
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
2.6K
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.7K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
152
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K